Texas A+M University Hyperbaric
Laboratory Case Study on Lyme
Disease:

The following is a excerpt from the study:
"The purpose of this study was to
determine if hyperbaric oxygen therapy
(HBOT) affects Lyme disease caused by
the spirochete Borrelia burgdorferi. It is well
known that this spirochete is a facultative
anaerobic organism which cannot survive in
a partial pressure of oxygen much greater
than 35 mm Hg. It also is well known that
when Lyme disease becomes chronic and
the spirochete is sequestered in cells
(particularly fibroblasts), the cell may
protect the spirochete against the antibiotic
which then is not fully effective. If the
spirochete is exposed to oxygen at a partial
pressure of 160 mm Hg or higher, it does
not survive. This can be achieved by
exposing the patient in a hyperbaric
chamber to a barometric pressure.

We exposed a total of 91subjects to
hyperbaric oxygen therapy 75 of whom
completed the study, at the above
mentioned oxygen pressure for between 10
and 153 treatments. All except 7 of them
experienced a significant improvement or
cessation of symptoms, in some cases,
lasting up to 6 years.

Based on our findings we believe that HBO
is an effective way to treat chronic Lyme
disease and that extending HBO
treatments may relieve symptoms
permanently."

When hyperbaric oxygen therapy
was used to treat a 14-year old
patient who had developed severe
crippling inflammatory arthritis as a
result of untreated Lyme disease,
the result of hyperbaric oxygen
treatment was that all pain
disappeared after three weeks and
the disease appeared to be halted
after several months of treatment."

For Further information about oxygen therapy in
the treatment of Lyme's Disease please visit
Hyperbaric Services of America at:
http://www.hyperbaricservices.com/html/lyme_criteria.html